Illumina Ventures: Timothy Stenzel, Jerry Steiner

Timothy Stenzel and Jerry Steiner have joined Illumina Ventures as advisors.

Stenzel is the former director of the US Food and Drug Administration's Office of In Vitro Diagnostics. He has also been chief operating officer of Invivoscribe, CSO of Quidel, and a faculty member at Duke University School of Medicine. He holds an MD and a PhD in microbiology and immunology from Duke.

Steiner is executive chairman of Pluton Biosciences, an Illumina Ventures portfolio company. Previously, he was executive VP of sustainability and global corporate affairs at Monsanto, and before that, Monsanto's VP of product and corporate strategy and general manager in the US and Europe. Earlier, he was part of the leadership team at Celera Genomics. He holds an MBA from Washington University in St. Louis and a BS in agricultural economics from the University of Wisconsin.